BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR
59 results:

  • 1. Rheumatoid arthritis increases the risk of malignant neoplasm of bone and articular cartilage: a two-sample bidirectional mendelian randomization study.
    Yang M; Su Y; Xu K; Xie J; Wen P; Liu L; Yang Z; Xu P
    Arthritis Res Ther; 2023 Nov; 25(1):219. PubMed ID: 37957703
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome.
    Guijarro F; López-Guerra M; Morata J; Bataller A; Paz S; Cornet-Masana JM; Banús-Mulet A; Cuesta-Casanovas L; Carbó JM; Castaño-Díez S; Jiménez-Vicente C; Cortés-Bullich A; Triguero A; Martínez-Roca A; Esteban D; Gómez-Hernando M; Álamo Moreno JR; López-Oreja I; Garrote M; Risueño RM; Tonda R; Gut I; Colomer D; Díaz-Beya M; Esteve J
    Blood Adv; 2023 Oct; 7(19):5799-5811. PubMed ID: 37450374
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. csf3r-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
    Guastafierro V; Ubezio M; Manes N; Milanesi C; Della Porta M; Bonometti A
    Leuk Lymphoma; 2023 Sep; 64(9):1566-1573. PubMed ID: 37395413
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A congenital csf3r mutation in chronic neutropenia reveals a vital role for a cytokine receptor extracellular hinge motif in the response to granulocyte colony-stimulating factor.
    Feyen J; Ernst MPT; van der Velden VHJ; Valk PJM; Broeders L; Touw IP; Raaijmakers MHGP
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30039. PubMed ID: 36316822
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Common variant rs6564851 near the beta-carotene oxygenase 1 gene is associated with plasma triglycerides levels in middle-aged Mexican men adults.
    León-Reyes G; Rivera-Paredez B; Hidalgo-Bravo A; Flores YN; Salmerón J; Velázquez-Cruz R
    Nutr Res; 2022 Jul; 103():30-39. PubMed ID: 35461060
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. G-CSF, the guardian of granulopoiesis.
    Mehta HM; Corey SJ
    Semin Immunol; 2021 Apr; 54():101515. PubMed ID: 34772606
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. New insight into the mechanism of granulocyte colony-stimulating factor (G-CSF) that induces the mobilization of neutrophils.
    Theyab A; Algahtani M; Alsharif KF; Hawsawi YM; Alghamdi A; Alghamdi A; Akinwale J
    Hematology; 2021 Dec; 26(1):628-636. PubMed ID: 34494505
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia.
    Dannenmann B; Klimiankou M; Oswald B; Solovyeva A; Mardan J; Nasri M; Ritter M; Zahabi A; Arreba-Tutusaus P; Mir P; Stein F; Kandabarau S; Lachmann N; Moritz T; Morishima T; Konantz M; Lengerke C; Ripperger T; Steinemann D; Erlacher M; Niemeyer CM; Zeidler C; Welte K; Skokowa J
    Cell Stem Cell; 2021 May; 28(5):906-922.e6. PubMed ID: 33894142
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. G-CSF in tumors: Aggressiveness, tumor microenvironment and immune cell regulation.
    Karagiannidis I; Salataj E; Said Abu Egal E; Beswick EJ
    Cytokine; 2021 Jun; 142():155479. PubMed ID: 33677228
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Effect of the unfolded protein response and oxidative stress on mutagenesis in csf3r: a model for evolution of severe congenital neutropenia to myelodysplastic syndrome/acute myeloid leukemia.
    Sapra A; Jaksik R; Mehta H; Biesiadny S; Kimmel M; Corey SJ
    Mutagenesis; 2020 Dec; 35(5):381-389. PubMed ID: 33511998
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Development of an immune-related prognostic index associated with osteosarcoma.
    Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
    Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML.
    Herrmann H; Sadovnik I; Eisenwort G; Rülicke T; Blatt K; Herndlhofer S; Willmann M; Stefanzl G; Baumgartner S; Greiner G; Schulenburg A; Mueller N; Rabitsch W; Bilban M; Hoermann G; Streubel B; Vallera DA; Sperr WR; Valent P
    Blood Adv; 2020 Oct; 4(20):5118-5132. PubMed ID: 33085758
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Inducible expression of a disease-associated
    Garg B; Mehta HM; Wang B; Kamel R; Horwitz MS; Corey SJ
    J Biol Chem; 2020 May; 295(21):7492-7500. PubMed ID: 32299910
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Homozygous c.130-131 ins A (pW44X) mutation in the HAX1 gene as the most common cause of congenital neutropenia in Turkey: Report from the Turkish Severe Congenital Neutropenia Registry.
    Yılmaz Karapınar D; Patıroğlu T; Metin A; Çalışkan Ü; Celkan T; Yılmaz B; Karakaş Z; Karapınar TH; Akıncı B; Özkınay F; Onay H; Yeşilipek MA; Akar HH; Tüysüz G; Tokgöz H; Özdemir GN; Aslan Kıykım A; Karaman S; Kılınç Y; Oymak Y; Küpesiz A; Olcay L; Keskin Yıldırım Z; Aydoğan G; Gökçe M; İleri T; Aral YZ; Bay A; Atabay B; Kaya Z; Söker M; Özdemir Karadaş N; Özbek U; Özsait Selçuk B; Özdemir HH; Uygun V; Tezcan Karasu G; Yılmaz Ş
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27923. PubMed ID: 31321910
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.
    Mehta RS; Holtan SG; Wang T; Hemmer MT; Spellman SR; Arora M; Couriel DR; Alousi AM; Pidala J; Abdel-Azim H; Ahmed I; Aljurf M; Askar M; Auletta JJ; Bhatt V; Bredeson C; Chhabra S; Gadalla S; Gajewski J; Gale RP; Gergis U; Hematti P; Hildebrandt GC; Inamoto Y; Kitko C; Khandelwal P; MacMillan ML; Majhail N; Marks DI; Mehta P; Nishihori T; Olsson RF; Pawarode A; Diaz MA; Prestidge T; Qayed M; Rangarajan H; Ringden O; Saad A; Savani BN; Seo S; Shah A; Shah N; Schultz KR; Solh M; Spitzer T; Szer J; Teshima T; Verdonck LF; Williams KM; Wirk B; Wagner J; Yared JA; Weisdorf DJ
    Blood Adv; 2019 May; 3(9):1441-1449. PubMed ID: 31053571
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Ultra-Sensitive
    Klimiankou M; Uenalan M; Kandabarau S; Nustede R; Steiert I; Mellor-Heineke S; Zeidler C; Skokowa J; Welte K
    Front Immunol; 2019; 10():116. PubMed ID: 30891028
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. G-CSF administration favours SDF-1 release and activation of neutrophils and monocytes in recipients of autologous peripheral blood progenitor cells.
    Gębura K; Butrym A; Chaszczewska-Markowska M; Wróbel T; Kuliczkowski K; Bogunia-Kubik K
    Cytokine; 2019 Apr; 116():38-47. PubMed ID: 30685602
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemia.
    Faisal M; Stark H; Büsche G; Schlue J; Teiken K; Kreipe HH; Lehmann U; Bartels S
    Cancer Med; 2019 Feb; 8(2):742-750. PubMed ID: 30635983
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mutation, drift and selection in single-driver hematologic malignancy: Example of secondary myelodysplastic syndrome following treatment of inherited neutropenia.
    Wojdyla T; Mehta H; Glaubach T; Bertolusso R; Iwanaszko M; Braun R; Corey SJ; Kimmel M
    PLoS Comput Biol; 2019 Jan; 15(1):e1006664. PubMed ID: 30615612
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection.
    Patel KP; Ruiz-Cordero R; Chen W; Routbort MJ; Floyd K; Rodriguez S; Galbincea J; Barkoh BA; Hatfield D; Khogeer H; Kanagal-Shamanna R; Yin CC; Zuo Z; Loghavi S; Ok CY; DiNardo CD; Luthra R; Medeiros LJ
    J Mol Diagn; 2019 Jan; 21(1):89-98. PubMed ID: 30577887
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.